TY - JOUR
T1 - Therapeutic approaches for chronic hepatitis C
T2 - a concise review
AU - Nawaz, Allah
AU - Manzoor, Azhar
AU - Ahmed, Saeed
AU - Ahmed, Naveed
AU - Abbas, Waseem
AU - Mir, Mushtaq Ahmad
AU - Bilal, Muhammad
AU - Sheikh, Alisha
AU - Ahmad, Saleem
AU - Jeelani, Ishtiaq
AU - Nakagawa, Takashi
N1 - Publisher Copyright:
Copyright © 2024 Nawaz, Manzoor, Ahmed, Ahmed, Abbas, Mir, Bilal, Sheikh, Ahmad, Jeelani and Nakagawa.
PY - 2023
Y1 - 2023
N2 - Hepatitis C virus (HCV) infection is a significant global health concern, prompting the need for effective treatment strategies. This in-depth review critically assesses the landscape of HCV treatment, drawing parallels between traditional interferon/ribavirin therapy historically pivotal in HCV management and herbal approaches rooted in traditional and complementary medicine. Advancements in therapeutic development and enhanced clinical outcomes axis on a comprehensive understanding of the diverse HCV genome, its natural variations, pathogenesis, and the impact of dietary, social, environmental, and economic factors. A thorough analysis was conducted through reputable sources such as Science Direct, PubMed, Scopus, Web of Science, books, and dissertations. This review primarily focuses on the intricate nature of HCV genomes and explores the potential of botanical drugs in both preventing and treating HCV infections.
AB - Hepatitis C virus (HCV) infection is a significant global health concern, prompting the need for effective treatment strategies. This in-depth review critically assesses the landscape of HCV treatment, drawing parallels between traditional interferon/ribavirin therapy historically pivotal in HCV management and herbal approaches rooted in traditional and complementary medicine. Advancements in therapeutic development and enhanced clinical outcomes axis on a comprehensive understanding of the diverse HCV genome, its natural variations, pathogenesis, and the impact of dietary, social, environmental, and economic factors. A thorough analysis was conducted through reputable sources such as Science Direct, PubMed, Scopus, Web of Science, books, and dissertations. This review primarily focuses on the intricate nature of HCV genomes and explores the potential of botanical drugs in both preventing and treating HCV infections.
KW - botanical drugs
KW - direct-acting antiviral agents (DAAs)
KW - hepatitis C
KW - hepatitis C virus
KW - hepatoprotective and antiviral properties of medicinal plants
UR - http://www.scopus.com/inward/record.url?scp=85183142029&partnerID=8YFLogxK
U2 - 10.3389/fphar.2023.1334160
DO - 10.3389/fphar.2023.1334160
M3 - 簡易調査
C2 - 38283838
AN - SCOPUS:85183142029
SN - 1663-9812
VL - 14
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 1334160
ER -
